GATA2 is a New Predisposition Gene for Familial Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Hamish S. Scott(South Australia Pathology), Marshall S. Horwitz(University of Washington), Ella Wilkins(Victorian Clinical Genetics Services), Andrew E. Timms, Catherine Carmichael(Hudson Institute), Meryl Altree(Women's and Children's Health Network), Richard J. D’Andrea(South Australia Pathology), Ming Lin(First Affiliated Hospital of Shantou University Medical College), Amandine Carmagnac(Walter and Eliza Hall Institute of Medical Research), Peter J Brautigan(South Australia Pathology), Christopher N Hahn(South Australia Pathology), Chung Hoow Kok(South Australian Health and Medical Research Institute), Anna Brown(South Australia Pathology), Robert Escher(Walter and Eliza Hall Institute of Medical Research), Jan Storek(University of Washington), Paul G. Ekert(Royal Children's Hospital), Xiaochun Li(Indiana University School of Medicine), Sarah Moore(South Australia Pathology), Ian D. Lewis, Milena Stanković(South Australia Pathology), Kathryn Friend(Women's and Children's Hospital), Peter Bardy(Royal Adelaide Hospital), Carolyn M Butcher(South Australia Pathology), Graeme Suthers(The University of Adelaide), Luen Bik To(Royal Adelaide Hospital), Chan‐Eng Chong(Cancer Research Malaysia)
Cited by 13
Related Papers
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
|Pharmacological Reviews|2010|857
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737